We aimed to investigate the time profile of circulating fractalkine and gene expression of its receptor CX3CR1 during AMI , and the influence of intracoronary autologous bone marrow stem cell ( mBMC ) transplantation ( given 6 days after AMI ) on fractalkine levels .